DOP2017000238A - COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY - Google Patents

COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY

Info

Publication number
DOP2017000238A
DOP2017000238A DO2017000238A DO2017000238A DOP2017000238A DO P2017000238 A DOP2017000238 A DO P2017000238A DO 2017000238 A DO2017000238 A DO 2017000238A DO 2017000238 A DO2017000238 A DO 2017000238A DO P2017000238 A DOP2017000238 A DO P2017000238A
Authority
DO
Dominican Republic
Prior art keywords
prevention
treatment
combination
protease inhibitor
active principle
Prior art date
Application number
DO2017000238A
Other languages
Spanish (es)
Inventor
Assandri Alessandro
Original Assignee
Eurodrug Laboratories B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurodrug Laboratories B V filed Critical Eurodrug Laboratories B V
Priority to DO2017000238A priority Critical patent/DOP2017000238A/en
Publication of DOP2017000238A publication Critical patent/DOP2017000238A/en

Links

Abstract

La invención se refiere a una combinación que comprende al menos un inhibidor de proteasa, que puede ser diferentes orígenes, tal como plantas, frutas, salvado de arroz, semillas de frijol, soja o papa y al menos un principio activo adicional, seleccionado de óxido de zinc, dexpantenol, pantenol, cloruro de benzalconio, cetrimida, clotrimazol, nistatina, dimeticona, aloe vera, o caléndula y a su uso en la prevención y/o tratamiento de lesiones de piel causadas por orina y/o heces y como adyuvante en la reparación de piel. La invención además se refiere a dicha combinación en asociación con principios activos adicionales y a su uso en la prevención y/o tratamiento de lesiones de piel causadas por proteasas en las heces y como adyuvante en la reparación de piel.The invention relates to a combination comprising at least one protease inhibitor, which may be different origins, such as plants, fruits, rice bran, beans, soybeans or potatoes and at least one additional active ingredient, selected from oxide. of zinc, dexpanthenol, panthenol, benzalkonium chloride, cetrimide, clotrimazole, nystatin, dimethicone, aloe vera, or calendula and its use in the prevention and / or treatment of skin lesions caused by urine and / or feces and as an adjuvant in the skin repair The invention also relates to said combination in association with additional active ingredients and its use in the prevention and / or treatment of skin lesions caused by proteases in the feces and as an adjuvant in skin repair.

DO2017000238A 2017-10-16 2017-10-16 COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY DOP2017000238A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2017000238A DOP2017000238A (en) 2017-10-16 2017-10-16 COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2017000238A DOP2017000238A (en) 2017-10-16 2017-10-16 COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY

Publications (1)

Publication Number Publication Date
DOP2017000238A true DOP2017000238A (en) 2018-04-30

Family

ID=62239787

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2017000238A DOP2017000238A (en) 2017-10-16 2017-10-16 COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY

Country Status (1)

Country Link
DO (1) DOP2017000238A (en)

Similar Documents

Publication Publication Date Title
ES2573524T3 (en) New anti-redness active ingredient and cosmetic compositions that comprise it
CL2020000220A1 (en) Compositions comprising amino acids for use in the treatment of diseases related to mitochondrial dysfunction.
AR097599A1 (en) A COMPOSITION THAT INCLUDES GUAÇATONGA AND AROEIRA EXTRACT, ITS USE AND A METHOD FOR THE PREVENTION AND / OR TREATMENT OF SIGNS CAUSED BY SKIN AGING
CR9816A (en) SYNERGETIC COMPOSITION AND METHOD OF USE
CO2017011778A2 (en) An inhibitor of csf-1r activity and pharmaceutical compositions comprising it
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
PH12021551070A1 (en) Pharmaceutical composition comprising histone deacetylase 6 inhibitors
BR112014000795A2 (en) Cosmetic and / or dermatological use of oligosaccharide compounds in the prevention and treatment of stretch marks.
CO2017010543A2 (en) Combination of at least one protease inhibitor and at least one active ingredient for use in the prevention and / or treatment of skin lesions
DOP2017000238A (en) COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY
CL2017002630A1 (en) Combination of at least one protease inhibitor and at least one active ingredient for use in the prevention and / or treatment of skin lesions
PH12020551100A1 (en) Bowel cleansing composition
BRPI1002094A2 (en) USE OF AT LEAST ONE SOLUBLE PEPTIDIC FORM, AND PROCESSES FOR SCREENING ANTI-AGE ASSETS AND CHARACTERIZING THE EFFECTIVENESS OF A TREATMENT
AR064214A1 (en) USE OF EPOTILONES IN THE TREATMENT OF OSTEOPOROSIS AND RELATED DISEASES
DK3727414T3 (en) SALVIA HAENKEI EXTRACT AS AN ACTIVE AGENT IN TISSUE REPETITION AND ARDANCING PROCESSES
PH12018000227B1 (en) A pharmaceutical composition for improving or preventing progression of chronic kidney disease
MX2019011951A (en) Bacterial secretome for use in the treatment of skin lesions.
WO2015044317A3 (en) Staphylococcus haemolyticus inhibitors for preventing and/or treating atopic dermatitis
PE20180161A1 (en) COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST ONE ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURIES
PH12016501448A1 (en) Antifungal composition
EP3338792A4 (en) Corneal damage prevention/treatment composition comprising thymosin beta 4 and citric acid as active ingredients
WO2011067608A8 (en) Treatment of allodynia and hyperalgesia
TH1701006167A (en) Inclusion of at least one protease inhibitor And at least one active ingredient for use in the prevention and / or treatment of skin lesions.
MX2020005682A (en) Extract of helichrysum gymnocephalum for the treatment and/or prevention of inflammatory dermatoses.
ECSP12012332A (en) ASSOCIATION OF INHIBITORS OF XANTINA OXIDASE AND THE INSTATINE AND ITS USE